The data shown below were collected from the profiles of 45,497 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
|
|---|---|
| Published in |
medRxiv, December 2022
|
| DOI | 10.1101/2022.12.17.22283625 |
| Authors |
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, James F. Simon, Amanda Hagen, Steven M. Gordon |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4708 | 10% |
| Brazil | 1075 | 2% |
| Japan | 737 | 2% |
| Canada | 725 | 2% |
| United Kingdom | 715 | 2% |
| France | 398 | <1% |
| Spain | 287 | <1% |
| Australia | 229 | <1% |
| Germany | 216 | <1% |
| Other | 2141 | 5% |
| Unknown | 34266 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 43932 | 97% |
| Practitioners (doctors, other healthcare professionals) | 661 | 1% |
| Scientists | 551 | 1% |
| Science communicators (journalists, bloggers, editors) | 293 | <1% |
| Unknown | 60 | <1% |